Health and financial analysis reinforces NIH's decision to fund Women's Health Initiative
aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
An in-depth analysis of final data from one of the Women’s Health Initiative
(WHI) Postmenopausal Hormone Therapy Trials has found that the
investment in WHI resulted in a return of $140 in net economic value
for each dollar invested in the trial.
The WHI, sponsored by the National Institutes of Health’s National Heart,
Lung, and Blood Institute (NHLBI), has followed women in the study since
1993. Results of the trial of estrogen plus progestin were published in 2002.
A paper examining the national post-study long-term financial and health
outcomes of the WHI was published today in the Annals of Internal Medicine.